Consolidated Statements of Cash Flows - USD ($) $ in Thousands	11 Months Ended	12 Months Ended
	Dec. 01, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net earnings (loss)	$ 47,105	$ (19,071)	$ (5,067)
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization expense	9,674	10,956	9,568
Net (gain) loss on disposition of assets	(53,014)	18	36
Net (gain) loss on derivatives and convertible debt	(6,330)	6,331	1,071
Loss on extinguishment of debt	4,476
Equity in (earnings) loss of joint venture		(80)	(190)
Distributions from cumulative earnings of joint venture			170
Amortization of deferred financing costs	910	1,210	1,267
Principal forgiveness on long-term debt	(2,299)
Stock-based compensation expense	450	173	1,026
Provision for deferred taxes		(421)	821
Changes in operating assets and liabilities:
Decrease in assets	142	531	1,172
Decrease in liabilities	(759)	(449)	(622)
Net cash provided by (used in) operating activities	355	(802)	9,252
Cash flows from investing activities:
Additions to hotel properties	(718)	(605)	(1,475)
Distributions in excess of cumulative earnings from joint venture		480	1,643
Hotel acquisitions		(7,193)
Net proceeds from sale of hotel assets	301,299	4	4,191
Net cash provided by (used in) investing activities	300,581	(7,314)	4,359
Cash flows from financing activities:
Deferred financing costs	(589)	(1,660)	(415)
Proceeds from long-term debt	4,584	47,264	1,500
Principal payments on long-term debt	(170,617)	(48,369)	(5,281)
Principal payments on convertible debt	(11,012)
Proceeds from convertible debt		10,000
Redemption of common units			(42)
Tax withholdings on stock compensation	(29)	(30)	(356)
Early repayment penalties	(2,992)
Extinguishment of interest rate cap	(413)
Cash dividends paid to common shareholders			(9,304)
Cash dividends paid to common unit holders			(36)
Cash dividends paid to preferred shareholders			(434)
Other items	(3)	(4)	(4)
Net cash provided by (used in) financing activities	(181,071)	7,201	(14,372)
Increase (decrease) in cash, cash equivalents, and restricted cash	119,865	(915)	(761)
Cash, cash equivalents, and restricted cash beginning of period	7,480	8,395	9,156
Cash, cash equivalents, and restricted cash end of period	127,345	7,480	8,395
Supplemental cash flow information:
Interest paid	9,092	7,272	6,732
Income taxes paid	103	119	307
Schedule of noncash investing and financing activities:
Debt assumed in acquisitions		34,080
Increase in accrued liabilities related to insurance premium financing agreement	(17)	207	22
Land option liability in acquisition		8,497
Fair value of operating partnership common units issued in acquisitions
Fair value of operating partnership common units converted to common stock			$ 595